UCP3 Gene

UCP3 — Uncoupling Protein 3

<div class="infobox infobox-gene">
<div class="infobox-header">UCP3</div>
<div class="infobox-row"><strong>Full Name:</strong> Uncoupling Protein 3</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 11q13.4</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> NCBI Gene 7352</div>
<div class="infobox-row"><strong>OMIM:</strong> 602248</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000175564</div>
<div class="infobox-row"><strong>UniProt ID:</strong> P55916</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Obesity, Type 2 diabetes, Metabolic syndrome, Mitochondrial myopathy</div>
</div>

Overview

Uncoupling Protein 3 (UCP3) is a mitochondrial anion carrier protein belonging to the mitochondrial carrier family (SLC25). While initially characterized for its role in non-shivering thermogenesis in skeletal muscle and brown adipose tissue, emerging research has revealed crucial functions in [neurons](/entities/neurons) that are highly relevant to neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease)[@cadenas2018] [1](https://pubmed.ncbi.nlm.nih.gov/10367879/).

UCP3 — Uncoupling Protein 3

<div class="infobox infobox-gene">
<div class="infobox-header">UCP3</div>
<div class="infobox-row"><strong>Full Name:</strong> Uncoupling Protein 3</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 11q13.4</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> NCBI Gene 7352</div>
<div class="infobox-row"><strong>OMIM:</strong> 602248</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000175564</div>
<div class="infobox-row"><strong>UniProt ID:</strong> P55916</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Obesity, Type 2 diabetes, Metabolic syndrome, Mitochondrial myopathy</div>
</div>

Overview

Uncoupling Protein 3 (UCP3) is a mitochondrial anion carrier protein belonging to the mitochondrial carrier family (SLC25). While initially characterized for its role in non-shivering thermogenesis in skeletal muscle and brown adipose tissue, emerging research has revealed crucial functions in [neurons](/entities/neurons) that are highly relevant to neurodegenerative diseases including [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease)[@cadenas2018] [1](https://pubmed.ncbi.nlm.nih.gov/10367879/).

UCP3 shares 73% amino acid sequence homology with [UCP2](/genes/ucp2) and belongs to a family of mitochondrial uncoupling proteins that dissipate the proton gradient across the inner mitochondrial membrane, converting metabolic energy into heat rather than ATP production.[@boss1999] However, UCP3 has distinct physiological functions and expression patterns that make it particularly important in the context of neurodegeneration [2](https://pubmed.ncbi.nlm.nih.gov/10512670/).
PMID: 15211595

Molecular Structure and Mechanism

Protein Architecture

UCP3 is a 312-amino acid protein encoded by the UCP3 gene located on chromosome 11q13.4. Like other members of the mitochondrial carrier protein family, UCP3 contains six transmembrane alpha-helices that traverse the inner mitochondrial membrane, forming a three-fold symmetrical structure. The protein operates as a homodimer, with each monomer capable of transporting protons or other small molecules across the mitochondrial inner membrane [3](https://pubmed.ncbi.nlm.nih.gov/17210927/).
PMID: 20211596

The active site of UCP3 contains several key residues involved in proton transport and regulation. Unlike [UCP1](/genes/ucp1), which is exclusively expressed in brown adipose tissue and specialized for thermogenesis, UCP3 is expressed in tissues with high metabolic activity, particularly skeletal muscle, with lower but functionally significant expression in [neurons](/entities/neurons) and [astrocytes](/cell-types/astrocytes) [4](https://pubmed.ncbi.nlm.nih.gov/32251685/).
PMID: 41309190

Bioenergetics Function

The primary biochemical function of UCP3 is to mediate mitochondrial uncoupling, a process that dissipates the proton electrochemical gradient generated by the electron transport chain. This uncoupling reduces the efficiency of ATP production but increases heat generation. In skeletal muscle, this function is thought to serve several purposes [5](https://pubmed.ncbi.nlm.nih.gov/18694201/):
PMID: 39843141

In the brain, UCP3 expression is particularly notable in [neurons](/entities/neurons) with high metabolic demands, including [dopaminergic neurons](/cell-types/dopaminergic-neurons) in the substantia nigra and [pyramidal neurons](/cell-types/pyramidal-neurons) in the [cortex](/brain-regions/cortex) [6](https://pubmed.ncbi.nlm.nih.gov/29555323/).

Role in Neurodegeneration

Alzheimer's Disease

UCP3 has emerged as a potentially important player in [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis through several mechanisms [7](https://pubmed.ncbi.nlm.nih.gov/34145678/):

Mitochondrial Dysfunction: Alzheimer's Disease is characterized by progressive mitochondrial dysfunction, with early defects in oxidative phosphorylation and ATP production. UCP3 expression is altered in AD brains, with some studies showing decreased UCP3 levels that may contribute to mitochondrial hyperpolarization and increased ROS production [8](https://pubmed.ncbi.nlm.nih.gov/19389556/).

Amyloid-β Toxicity: Amyloid-beta (Aβ) peptides, the hallmark aggregates of AD, directly impair mitochondrial function. UCP3 appears to be protective against Aβ-induced mitochondrial damage, potentially by reducing oxidative stress and maintaining mitochondrial membrane potential [9](https://pubmed.ncbi.nlm.nih.gov/21807124/).

Tau Pathology: Tau pathology spreads in part through mitochondrial dysfunction in affected neurons. UCP3 may help neurons cope with the metabolic stress imposed by tau aggregates, though this protective mechanism appears insufficient in established disease [10](https://pubmed.ncbi.nlm.nih.gov/31178912/).

Neuroinflammation: Metaflammation is a key contributor to AD progression. UCP3 in [microglia](/cell-types/microglia) and [astrocytes](/cell-types/astrocytes) may modulate the inflammatory response, though the exact mechanisms remain under investigation [11](https://pubmed.ncbi.nlm.nih.gov/35093567/).

Parkinson's Disease

In [Parkinson's Disease](/diseases/parkinsons-disease), UCP3 plays particularly important roles due to the high metabolic demands of [dopaminergic neurons](/cell-types/dopaminergic-neurons) in the substantia nigra [12](https://pubmed.ncbi.nlm.nih.gov/36797245/):

Dopaminergic Neuron Vulnerability: The substantia nigra pars compacta (SNc) dopaminergic neurons have exceptionally high metabolic requirements for dopamine synthesis, packaging, and release. UCP3 helps maintain mitochondrial function under these demanding conditions, and its expression is particularly high in these neurons [13](https://pubmed.ncbi.nlm.nih.gov/24152981/).

Alpha-Synuclein Toxicity: Like Aβ in AD, alpha-synuclein aggregates in PD impair mitochondrial function. UCP3 expression is upregulated in PD models, potentially as a compensatory mechanism, though this response is often insufficient to prevent neurodegeneration [14](https://pubmed.ncbi.nlm.nih.gov/18444152/).

Mitochondrial Quality Control: PD is characterized by mitophagy defects and accumulation of dysfunctional mitochondria. UCP3 appears to play a role in mitochondrial quality control, and genetic variants in UCP3 may influence PD risk [15](https://pubmed.ncbi.nlm.nih.gov/16571889/).

Oxidative Stress: Both environmental and genetic forms of PD involve significant oxidative stress. UCP3-mediated uncoupling can reduce ROS production by limiting mitochondrial membrane potential, providing a neuroprotective effect [16](https://pubmed.ncbi.nlm.nih.gov/32790123/).

Other Neurodegenerative Conditions

Amyotrophic Lateral Sclerosis (ALS): UCP3 expression is altered in ALS models and patients. The protein may play a protective role against motor neuron degeneration through its effects on mitochondrial function and oxidative stress [17](https://pubmed.ncbi.nlm.nih.gov/29789012/).

Huntington's Disease: Mitochondrial dysfunction is a key feature of Huntington's disease. UCP3 may help neurons cope with the metabolic abnormalities caused by mutant huntingtin protein [18](https://pubmed.ncbi.nlm.nih.gov/15039133/).

Diabetic Neuropathy: Metabolic dysfunction in diabetes often leads to peripheral neuropathy. UCP3 in peripheral neurons may provide protection against glucose-induced mitochondrial dysfunction [19](https://pubmed.ncbi.nlm.nih.gov/26118656/).

Expression Pattern

Brain Regions

UCP3 is expressed throughout the [brain](/brain-regions/brain-overview), with notable expression in:

• Cerebral Cortex: Higher expression in [pyramidal neurons](/cell-types/pyramidal-neurons) of layers 4-5
• Hippocampus: Expression in [CA1](/brain-regions/hippocampus) and [CA3](/brain-regions/hippocampus) neurons
• Basal Ganglia: High expression in [striatal medium spiny neurons](/cell-types/striatal-msn-neurons)
• Substantia Nigra: Particularly high expression in [dopaminergic neurons](/cell-types/dopaminergic-neurons)
• Cerebellum: Expression in [Purkinje cells](/cell-types/purkinje-cells)

Cellular Expression

Within the brain, UCP3 is expressed in:

• [Neurons](/entities/neurons) — primary expression site in brain
• [Astrocytes](/cell-types/astrocytes) — lower expression than neurons
• [Microglia](/cell-types/microglia) — minimal expression
• [Oligodendrocytes](/cell-types/oligodendrocytes) — limited expression

• Skeletal muscle (type I and II fibers)
• Brown adipose tissue
• Heart
• [Beta cells of pancreas](/cell-types/beta-cells)

Protein Interactions and Pathways

Key Interacting Proteins

UCP3 interacts with several proteins relevant to neurodegeneration:

Signaling Pathways

UCP3 is regulated by several key signaling pathways:

Thyroid Hormone Signaling: T3 upregulates UCP3 expression, linking metabolic rate to thermogenesis [21](https://pubmed.ncbi.nlm.nih.gov/19584908/)

PPAR Signaling: PPAR-alpha and PPAR-gamma agonists increase UCP3 expression

AMP-Activated Protein Kinase (AMPK): Activated during energy stress, increases UCP3 expression

Sirtuin Pathways: SIRT3 deacetylates and activates UCP3 in mitochondria

Genetic Variants and Disease Risk

Known Variants

Several UCP3 polymorphisms have been associated with metabolic and neurodegenerative diseases:

• -55C>T (rs1800849): Associated with obesity and type 2 diabetes risk
• -866G>A (rs659366): Linked to type 2 diabetes and metabolic syndrome
• Ala55Val (rs3785909): May affect UCP3 activity

Association with Neurodegeneration

While direct associations between UCP3 variants and AD/PD risk are less established than for some other genes, the protein's role in mitochondrial function suggests it may modify disease risk. Studies have shown:

• Certain UCP3 variants may influence age of onset in PD
• UCP3 expression differences may explain some population-level variations in AD prevalence
• Epigenetic regulation of UCP3 may contribute to sporadic neurodegeneration

Therapeutic Implications

Small Molecule Modulators

Several approaches to modulate UCP3 activity therapeutically are under investigation [22](https://pubmed.ncbi.nlm.nih.gov/):

UCP3 Agonists: Compounds that increase UCP3 activity could provide neuroprotection by:

• Reducing mitochondrial ROS production
• Improving metabolic flexibility
• Protecting against excitotoxicity

• Improving metabolic efficiency in certain conditions
• Potentially enhancing memory function in AD models

Gene Therapy Approaches

Gene therapy strategies to increase UCP3 expression are being explored:

• Viral vector delivery of UCP3 to specific brain regions
• CRISPR-based approaches to upregulate endogenous UCP3
• Cell-type specific promoters for neuronal expression

Target Validation

UCP3 as a therapeutic target requires careful validation:

• UCP3 knockout mice show increased oxidative stress but normal development
• UCP3 transgenic mice show improved metabolic parameters
• Human studies suggest UCP3 as a modifier rather than primary cause of neurodegeneration

Biomarker Potential

UCP3 has potential as a biomarker for neurodegenerative diseases:

Peripheral Biomarkers: UCP3 expression in blood cells may correlate with brain UCP3 status

Cerebrospinal Fluid: UCP3 levels in CSF may reflect neuronal mitochondrial function

Imaging: PET tracers targeting UCP3 may visualize mitochondrial dysfunction in vivo

Research Directions

Several key questions remain about UCP3 in neurodegeneration:

Cross-Links

• [UCP3 Protein](/proteins/ucp3-protein)
• [UCP2 Gene](/genes/ucp2)
• [UCP1 Gene](/genes/ucp1)
• [Mitochondrial Dysfunction](/mechanisms/mitochondrial-dysfunction)
• [Oxidative Stress](/mechanisms/oxidative-stress)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
• [Astrocytes](/cell-types/astrocytes)

See Also

• [Genes Directory](/genes/)
• [Proteins Directory](/proteins/)
• [Mechanisms Directory](/mechanisms/)
• [Neurodegeneration Overview](/diseases/neurodegeneration)
• [Mitochondrial Biogenesis](/mechanisms/mitochondrial-biogenesis)

External Links

• [NCBI Gene: UCP3](https://www.ncbi.nlm.nih.gov/gene/7352)
• [Ensembl: UCP3](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000175564)
• [UniProt: UCP3](https://www.uniprot.org/uniprot/P55916)
• [OMIM: UCP3](https://www.omim.org/entry/602248)

References